2-Chloro-5-fluoro-3-methylphenylboronic acid, 95%, 250mg

Ruthenium dioxide hydrate, 95.0%, 10g

Methanone, (4-chlorophenyl)[4-(8-nitro-5-quinolinyl)-1-piperazinyl]-, 97%, 1g

1-(4-Fluorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid, 95.0%, 100mg

Closing caps LABOCAP for 15/16 mm, silver 100 pcs

1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95.0%, 10g

2,6-Bis[(2S,5S)-4,4-diphenyl-1-aza-3-oxabicyclo[3.3.0]octan-2-yl]pyridine>90.0%(HPLC)50mg

1,2,3,4-Tetrahydro-2,7-naphthyridine hydrochloride, 95.0%, 100mg

Bis((S)-4-isobutyl-4,5-dihydrooxazol-2-yl)methane, 97%, 250mg

Methyl 2-bromo-2-(4-nitrophenyl)acetate, 95+%, 1g

DIMETHYL 6-METHYL-1H-INDAZOLE-3,5-DICARBOXYLATE, 95.0%, 5g

6-Fluoro-2-methylpyridin-3-ol, 97%, 100mg

Tantalum(V) oxide powder 99.99% 50 g